Aterian, Inc. (ATER)
NASDAQ: ATER · IEX Real-Time Price · USD
2.920
+0.040 (1.39%)
At close: Jul 19, 2024, 4:00 PM
2.970
+0.050 (1.71%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Aterian Revenue
Aterian had revenue of $127.90M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $20.21M. In the year 2023, Aterian had annual revenue of $142.57M.
Revenue (ttm)
$127.90M
Revenue Growth
-40.34%
P/S Ratio
0.20
Revenue / Employee
$1,121,939
Employees
114
Market Cap
25.05M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 142.57M | -78.60M | -35.54% |
Dec 31, 2022 | 221.17M | -26.60M | -10.73% |
Dec 31, 2021 | 247.77M | 62.06M | 33.42% |
Dec 31, 2020 | 185.70M | 71.25M | 62.26% |
Dec 31, 2019 | 114.45M | 41.17M | 56.19% |
Dec 31, 2018 | 73.28M | 36.82M | 100.99% |
Dec 31, 2017 | 36.46M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
The Container Store Group | 847.78M |
Yoshitsu | 195.68M |
YY Group Holding | 31.77M |
Perfect Moment | 24.44M |
Vicinity Motor | 21.79M |
Chanson International Holding | 17.25M |
RAVE Restaurant Group | 11.89M |
Jiuzi Holdings | 5.93M |
ATER News
- 25 days ago - Aterian Announces Leadership Changes & Improved Second Quarter 2024 Net Revenue and Adjusted EBITDA Ranges - GlobeNewsWire
- 6 weeks ago - Aterian Investment Partners Acquires Contract Pharmaceuticals Limited - Business Wire
- 2 months ago - Aterian Reports First Quarter 2024 Results - GlobeNewsWire
- 3 months ago - Aterian Sets Date for First Quarter 2024 Earnings Announcement & Investor Conference Call - GlobeNewsWire
- 3 months ago - Aterian Announces Improved First Quarter 2024 Net Revenue and Adjusted EBITDA Ranges - GlobeNewsWire
- 3 months ago - Aterian Investment Partners to Recapitalize CPL, a Leading Pharmaceutical Contract Development and Manufacturing Organization - Business Wire
- 4 months ago - Aterian Announces Reverse Stock Split - GlobeNewsWire
- 4 months ago - Aterian Reports Fourth Quarter & Full Year 2023 Results - GlobeNewsWire